Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Baldini

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Haematologica|October 5, 2019
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trialSara Bringhen, Mattia D'Agostino, Laura Paris, et al.
Blood|February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical useLuca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trialsMattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Blood|January 24, 2015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic featuresAlberto J Arribas, Andrea Rinaldi, Afua A Mensah, et al.
Journal of Hematology & Oncology|January 11, 2019
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trialIlaria Saltarella, Fortunato Morabito, Nicola Giuliani, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood Advances|November 13, 2020
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myelomaTiziana Bruno, Francesca De Nicola, Giacomo Corleone, et al.
Journal of Cancer Research and Clinical Oncology|April 21, 2018
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysisChiara Cerrato, Francesco Di Raimondo, Lorenzo De Paoli, et al.
La Radiologia Medica|January 16, 2022
Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilationGiorgia Dalpiaz, Lorenzo Gamberini, Aldo Carnevale, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Haematologica|October 5, 2019
Lenalidomide-based induction and maintenance in elderly newly diagnosed multiple myeloma patients: updated results of the EMN01 randomized trialSara Bringhen, Mattia D'Agostino, Laura Paris, et al.
Blood|February 24, 2006
Splenic marginal zone lymphoma: a prognostic model for clinical useLuca Arcaini, Mario Lazzarino, Nora Colombo, et al.
Critical Reviews in Oncology/Hematology|November 19, 2018
Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trialsMattia D'Agostino, Lorenzo De Paoli, Concetta Conticello, et al.
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
Blood|January 24, 2015
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic featuresAlberto J Arribas, Andrea Rinaldi, Afua A Mensah, et al.
Journal of Hematology & Oncology|January 11, 2019
Prognostic or predictive value of circulating cytokines and angiogenic factors for initial treatment of multiple myeloma in the GIMEMA MM0305 randomized controlled trialIlaria Saltarella, Fortunato Morabito, Nicola Giuliani, et al.
Hematological Oncology|July 17, 2010
Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcomeEkaterina Chigrinova, Michael Mian, Marta Scandurra, et al.
Blood Advances|November 13, 2020
Che-1/AATF-induced transcriptionally active chromatin promotes cell proliferation in multiple myelomaTiziana Bruno, Francesca De Nicola, Giacomo Corleone, et al.
Journal of Cancer Research and Clinical Oncology|April 21, 2018
Maintenance in myeloma patients achieving complete response after upfront therapy: a pooled analysisChiara Cerrato, Francesco Di Raimondo, Lorenzo De Paoli, et al.
La Radiologia Medica|January 16, 2022
Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilationGiorgia Dalpiaz, Lorenzo Gamberini, Aldo Carnevale, et al.
Pageof 16